Britain starts recruiting for real-world COVID antiviral trial
LONDON (Reuters) – British researchers on Wednesday started recruitment for a clinical trial to test antiviral COVID-19 treatments for use in people early on in the disease who are at higher risks of complications, starting with Merck’s molnupiravir. Britain became the first country in the world to approve molnupiravir, which was jointly developed by U.S.-based …
Britain starts recruiting for real-world COVID antiviral trial Read More »